ABUS - Arbutus Biopharma reports 2023 cash position of ~$132M as of Dec. 31 2023
2024-01-08 12:31:33 ET
More on Arbutus Biopharma
- Arbutus Biopharma Corporation (ABUS) Q3 2023 Earnings Call Transcript
- Putting Arbutus Biopharma Back In The Spotlight
- Arbutus Biopharma GAAP EPS of -$0.12 misses by $0.01, revenue of $4.66M misses by $0.06M, reduces 24% workforce
- Seeking Alpha’s Quant Rating on Arbutus Biopharma
- Historical earnings data for Arbutus Biopharma
For further details see:
Arbutus Biopharma reports 2023 cash position of ~$132M as of Dec. 31, 2023